Prednisolone/Levofloxacin

泼尼松龙/左氧氟沙星

Report date: 2022/06/27 20:00:35

Base Information

Drug NamePrednisolone/Levofloxacin
Drug Alias Name左氧氟沙星/泼尼松龙Levofloxacin and PrednisolonePrednisolone and Levofloxacin左氧氟沙星泼尼松龙prednisolone A/Levofloxacin +[8] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionBacterial DNA gyrase inhibitorsGlucocorticoid receptor agonists
TargetsTopoisomerase IIGlucocorticoid receptorBacterial DNA gyrase
Therapy Area/IndicationsKeratitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes PrednisoloneLevofloxacin
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPiramal Healthcare LtdAllergan IncCardinal Health (China) Pharmaceutical Enterprise Manage Co Ltd
Active IndicationsN/A
Inactive IndicationsKeratitis

Other Information

ATC CodeN/A
Related LinksN/A